Talk about a good day for the John Carroll men’s basketball team. On Feb. 23, the Ohio Athletic Conference released its men’s basketball awards and the No. 3-ranked and 24-2 Blue Streaks took home two ...
High-bleeding-risk (HBR) patients taking an oral anticoagulant (OAC), as well as those who were not, had similar rates of ischemic and net adverse events in the MASTER DAPT trial, no matter whether ...
Jan. 6—John Carroll's time as a member of the Ohio Athletic Conference is reportedly coming to an end. According to a Jan. 5 report by Division III college basketball guru Bob Quillman of the Q-Cast, ...
Despite secondary prevention with oral anticoagulation (OAC), the risk for recurrent ischemic stroke (IS) and mortality is high in patients with atrial fibrillation (AF). However, OAC discontinuation ...
In the OCEANIC-AF trial, asundexian resulted in a small increase in the rates of stroke and lowered bleeding compared with apixaban in patients with atrial fibrillation (AF) who were naive to oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results